Indian Journal of Clinical and Experimental Ophthalmology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Review Article
Author Details :
Volume : 4, Issue : 3, Year : 2018
Article Page : 300-303
https://doi.org/10.18231/2395-1451.2018.0067
Abstract
Serious complications during or after strabismus surgery are infrequent. This article gives a brief idea of the complications either local or systemic that can occur during or after squint surgery. Meticulous hemostasis is required at each step in the procedure, whichever conjunctival approach to the muscle is used. Particular caution is required with patients who have thin sclera (such as myopes), have a history of scleritis, previous scleral procedures. The surgeon must be aware of the detailed surgical anatomy of extraocular muscles (eg.location of contiguous vortex veins, especially during oblique muscle surgery).
Keywords: Extraocular, Muscles, Strabismus.
How to cite : Sharma N, Sharma R, Sharma B D, Khan A, Strabismus surgery complications. Indian J Clin Exp Ophthalmol 2018;4(3):300-303
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
